ZFPL1 and colorectal carcinoma: Although no significant difference in OS was observed in these external cohorts (Figure S3D, Supporting Information), they showed that CRC patients with high ZFPL1 expression had reduced relapse‐free survival (RFS) (Figure S3E, Supporting Information).